SAMHD1 is a deoxynucleoside triphosphate (dNTP) triphosphohydrolase and can mitigate the anti-tumor effect of DAC by converting 5-aza-dCTP to its inactive form 5-aza-dC (Oellerich et al, 2019). This evidence concerns the gene SAMHD1 and neoplasm.